2016-09-15 12:17:15 UTC

Future Biomarkers to Assess IBD Activity

Sept. 15, 2016

On-demand recording: Dr. David T. Rubin discusses current and future biomarkers for IBD, and also new tools that could help IBD patients.

Select presentations from the 2016 AGA Tech Summit are now available in the Education section of the AGA website. One you won’t want to miss: David T. Rubin, MD, AGAF, discussing future biomarkers to assess IBD disease activity. During his presentation, he provides a framework for biomarkers in IBD, discussing:

  • Currently available biomarkers in IBD.
  • New tools of interest for IBD patients.
  • The utility of serologies and genetic markers.
  • Future directions in therapeutic drug monitoring.

Watch below, or check out other recordings from the AGA Tech Summit or AGA’s IBD on-demand resources.

More on Crohn's Disease

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Building an IBD Specialty Clinic from the Ground Up

Feb. 7, 2018

Gastro One in Tennessee developed an IBD clinic within their practice, which decreased emergency room visits by 70 percent.

4 New & Noteworthy IBD Drug Studies

Jan. 30, 2018

We recommend reviewing these four abstracts from the Crohn’s & Colitis Congress to keep informed on IBD treatment options.